Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Medically reviewed by Anju Goel, MD Up to 20% of people who get COVID-19 experience skin and nail changes. COVID nails is a ...

A nurse practitioner gives her advice for managing adverse events during treatment with talquetamab for multiple myeloma.

You’re talking about arguably the best defensive third baseman if you look at his numbers ... a lock until the end of next season. “I do (think he’s back next season) And I mean, picking ...

Things You Can Do to Manage Your Eye ... Tell them you have multiple myeloma so they can look for any signs of eye problems. Take care of eye problems like cataracts or diabetic retinopathy.

For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events (MDEs) known as CRAB: Diagnosis also required -- and still does -- the ...

Minimal residual disease (MRD) is a key focus in multiple myeloma treatment ... for every patient, nor does she use It to make decisions on who should receive a transplant. “But,” she said, “my ...

More information: Rahul Banerjee et al, Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis, Blood (2024). DOI: 10.1182/blood ...

there are ups and downs for many patients with multiple myeloma. Yet with courage and hope like Diane and Todd’s, those waves can be ridden like a pro. “We do not have control over the hand we ...

A GSK medicine that was pulled from the market after failing its confirmatory test in multiple myeloma has new data from a Phase 3 study evaluating it as an earlier line of treatment, and the ...

Daratumumab, an anti-CD38 monoclonal antibody, has been approved for the treatment of multiple myeloma. Data are needed regarding the use of daratumumab for high-risk smoldering multiple myeloma ...

IMROZ represents a landmark study in multiple myeloma and is the first global Phase ... Mohty agreed: “It looks like if you are relatively old and fit you can do very well with Isa-VRd, and that is ...